Cigna Group/$CI
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
- Ticker
- $CI
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 66,685
- Headquarters
- Bloomfield, United States
- Website
- www.thecignagroup.com
Cigna Group Metrics
BasicAdvanced
$79B
12.33
$24.18
0.30
$6.19
2.09%
Price and volume
Market cap
$79B
Beta
0.3
52-week high
$316.27
52-week low
$239.51
Average daily volume
1.6M
Dividend rate
$6.19
Financial strength
Current ratio
0.846
Quick ratio
0.687
Long term debt to equity
0.678
Total debt to equity
0.743
Dividend payout ratio (TTM)
25.31%
Interest coverage (TTM)
7.78%
Profitability
EBITDA (TTM)
12,758
Gross margin (TTM)
9.14%
Net profit margin (TTM)
2.27%
Operating margin (TTM)
3.90%
Effective tax rate (TTM)
19.17%
Revenue per employee (TTM)
$4,230,000
Management effectiveness
Return on assets (TTM)
4.46%
Return on equity (TTM)
16.76%
Valuation
Price to earnings (TTM)
12.332
Price to revenue (TTM)
0.279
Price to book
1.85
Price to tangible book (TTM)
-2.64
Price to free cash flow (TTM)
8.637
Free cash flow yield (TTM)
11.58%
Free cash flow per share (TTM)
34.529
Dividend yield (TTM)
2.08%
Forward dividend yield
2.09%
Growth
Revenue change (TTM)
7.77%
Earnings per share change (TTM)
32.61%
3-year revenue growth (CAGR)
14.90%
10-year revenue growth (CAGR)
21.97%
3-year earnings per share growth (CAGR)
3.06%
10-year earnings per share growth (CAGR)
12.11%
3-year dividend per share growth (CAGR)
9.32%
10-year dividend per share growth (CAGR)
65.43%
What the Analysts think about Cigna Group
Analyst ratings (Buy, Hold, Sell) for Cigna Group stock.
Analyst projections of the future price of Cigna Group stock.
Bulls say / Bears say
Cigna beat second-quarter earnings expectations and raised its 2026 adjusted EPS floor to $30.45, with growth in both Evernorth and Cigna Healthcare. Reuters said strength in specialty drugs helped drive the improved outlook. (Reuters, The Cigna Group)
At its September investor day, Cigna set a target of 10% to 14% annual adjusted EPS growth through 2030 and about $50 billion of cumulative operating cash flow. If delivered, that would support continued investment and shareholder returns. (PR Newswire)
The PBM business has shown strong client retention, and Cigna said secured new business for 2027 already exceeded the prior two selling seasons combined. Employers have also shown early interest in its upcoming rebate-free Signature model, which could help retain business as PBM contracts change. (Fierce Healthcare)
Medical-cost pressure could constrain health-plan margins: Cigna said it raised premiums to cover expected increases in medical costs, and its 2026 medical care ratio outlook remains 83.7% to 84.7%. A higher-than-expected claims trend could put that outlook under strain. (The Cigna Group)
Regulation threatens parts of Express Scripts’ integrated PBM and pharmacy model. Tennessee’s new law bars PBM owners from operating pharmacies or dispensing medicines, and Express Scripts has sued to block it; the law is due to take effect in 2028. (Reuters, Healthcare Dive)
Evernorth’s Pharmacy Benefit Services adjusted operating income fell 27% in the second quarter, which Cigna attributed largely to large-client renewals and customer initiatives. That near-term weakness highlights the cost and execution risk of defending PBM clients while shifting to a new model. (The Cigna Group)
Data summarised monthly by Lightyear AI. Last updated on 14 Oct 2026.
Cigna Group Financial Performance
Revenues and expenses
Cigna Group Earnings Performance
Company profitability
Upcoming events
Cigna Group News
AllArticlesVideos
Funds containing Cigna Group
AllUSDEURGBP
Fund name | Fund size | $CI weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced€CBUF | $683M | 1.49% |
iShares MSCI World Health Care Sector Advanced£WHCA | $362M | 1.49% |
Invesco Health Care S&P US Select Sector£XLVP | $552M | 1.20% |
Invesco Health Care S&P US Select Sector$XLVS | $552M | 1.20% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 1.18% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.